{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:59:05Z","timestamp":1791655145768,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T00:00:00Z","timestamp":1467936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T00:00:00Z","timestamp":1467936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 1010 SyNergy"],"award-info":[{"award-number":["EXC 1010 SyNergy"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC grant Agreement No. 321366\u2010Amyloid"],"award-info":[{"award-number":["ERC grant Agreement No. 321366\u2010Amyloid"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Legacy of Mrs. Ammer"},{"DOI":"10.13039\/100000916","name":"The MetLife Award","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2016,9,1]]},"DOI":"10.15252\/emmm.201606370","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T01:15:05Z","timestamp":1468286105000},"page":"992-1004","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":174,"title":["TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance"],"prefix":"10.1038","volume":"8","author":[{"given":"Xianyuan","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Bohrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Liesz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fargol","family":"Mazaheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Capell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Feederle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Knuesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Kleinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2629-0723","authenticated-orcid":false,"given":"Christian","family":"Haass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,8]]},"reference":[{"key":"BFEMMM201606370_CR1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tins.2016.01.003","volume":"39","author":"S Barao","year":"2016","unstructured":"Barao S, Moechars D, Lichtenthaler SF, De Strooper B (2016) BACE1 Physiological Functions May Limit Its Use as Therapeutic Target for Alzheimer's Disease. Trends Neurosci 39: 158\u2013169","journal-title":"Trends Neurosci"},{"key":"BFEMMM201606370_CR2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","volume":"6","author":"F Bard","year":"2000","unstructured":"Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson\u2010Wood K et\u00a0al (2000) Peripherally administered antibodies against amyloid beta\u2010peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6: 916\u2013919","journal-title":"Nat Med"},{"key":"BFEMMM201606370_CR3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JAD-2011-110977","volume":"28","author":"B Bohrmann","year":"2012","unstructured":"Bohrmann B, Baumann K, Benz J, Gerber F, Huber W, Knoflach F, Messer J, Oroszlan K, Rauchenberger R, Richter WF et\u00a0al (2012) Gantenerumab: a novel human anti\u2010Abeta antibody demonstrates sustained cerebral amyloid\u2010beta binding and elicits cell\u2010mediated removal of human amyloid\u2010beta. J Alzheimer's Dis 28: 49\u201369","journal-title":"J Alzheimer's Dis"},{"key":"BFEMMM201606370_CR4","doi-asserted-by":"crossref","first-page":"934.e7","DOI":"10.1016\/j.neurobiolaging.2013.09.017","volume":"35","author":"B Borroni","year":"2014","unstructured":"Borroni B, Ferrari F, Galimberti D, Nacmias B, Barone C, Bagnoli S, Fenoglio C, Piaceri I, Archetti S, Bonvicini C et\u00a0al (2014) Heterozygous TREM2 mutations in frontotemporal dementia. Neurobiol Aging 35: 934.e7\u2013934.e10","journal-title":"Neurobiol Aging"},{"key":"BFEMMM201606370_CR5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/jamaneurol.2013.6237","volume":"71","author":"J Cady","year":"2014","unstructured":"Cady J, Koval ED, Benitez BA, Zaidman C, Jockel\u2010Balsarotti J, Allred P, Baloh RH, Ravits J, Simpson E, Appel SH et\u00a0al (2014) TREM2 variant p. R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA Neurol 71: 449\u2013453","journal-title":"JAMA Neurol"},{"key":"BFEMMM201606370_CR6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00401-015-1388-1","volume":"129","author":"C Cantoni","year":"2015","unstructured":"Cantoni C, Bollman B, Licastro D, Xie M, Mikesell R, Schmidt R, Yuede CM, Galimberti D, Olivecrona G, Klein RS et\u00a0al (2015) TREM2 regulates microglial cell activation in response to demyelination in\u00a0vivo. Acta Neuropathol 129: 429\u2013447","journal-title":"Acta Neuropathol"},{"key":"BFEMMM201606370_CR7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/35008626","volume":"2","author":"A Capell","year":"2000","unstructured":"Capell A, Steiner H, Romig H, Keck S, Baader M, Grim MG, Baumeister R, Haass C (2000) Presenilin\u20101 differentially facilitates endoproteolysis of the beta\u2010amyloid precursor protein and Notch. Nat Cell Biol 2: 205\u2013211","journal-title":"Nat Cell Biol"},{"key":"BFEMMM201606370_CR8","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/emboj.2013.146","volume":"32","author":"C Cheret","year":"2013","unstructured":"Cheret C, Willem M, Fricker FR, Wende H, Wulf\u2010Goldenberg A, Tahirovic S, Nave KA, Saftig P, Haass C, Garratt AN et\u00a0al (2013) Bace1 and Neuregulin\u20101 cooperate to control formation and maintenance of muscle spindles. EMBO J 32: 2015\u20132028","journal-title":"EMBO J"},{"key":"BFEMMM201606370_CR9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-0-387-72009-8_13","volume":"602","author":"M Colonna","year":"2007","unstructured":"Colonna M, Turnbull I, Klesney\u2010Tait J (2007) The enigmatic function of TREM\u20102 in osteoclastogenesis. Adv Exp Med Biol 602: 97\u2013105","journal-title":"Adv Exp Med Biol"},{"key":"BFEMMM201606370_CR10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrn.2016.7","volume":"17","author":"M Colonna","year":"2016","unstructured":"Colonna M, Wang Y (2016) TREM2 variants: new keys to decipher Alzheimer disease pathogenesis. Nat Rev Neurosci 17: 201\u2013207","journal-title":"Nat Rev Neurosci"},{"key":"BFEMMM201606370_CR11","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.186.7.1027","volume":"186","author":"MT Crowley","year":"1997","unstructured":"Crowley MT, Costello PS, Fitzer\u2010Attas CJ, Turner M, Meng F, Lowell C, Tybulewicz VL, DeFranco AL (1997) A critical role for Syk in signal transduction and phagocytosis mediated by Fcgamma receptors on macrophages. J Exp Med 186: 1027\u20131039","journal-title":"J Exp Med"},{"issue":"726","key":"BFEMMM201606370_CR12","first-page":"e711","volume":"35","author":"E Cuyvers","year":"2014","unstructured":"Cuyvers E, Bettens K, Philtjens S, Van Langenhove T, Gijselinck I, van der Zee J, Engelborghs S, Vandenbulcke M, Van Dongen J, Geerts N et\u00a0al (2014) Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia. Neurobiol Aging 35(726): e711\u2013e729","journal-title":"Neurobiol Aging"},{"key":"BFEMMM201606370_CR13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","volume":"369","author":"RS Doody","year":"2013","unstructured":"Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, He F, Sun X, Thomas RG et\u00a0al (2013) A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med 369: 341\u2013350","journal-title":"N Engl J Med"},{"key":"BFEMMM201606370_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1742-2094-7-61","volume":"7","author":"S Fleisher\u2010Berkovich","year":"2010","unstructured":"Fleisher\u2010Berkovich S, Filipovich\u2010Rimon T, Ben\u2010Shmuel S, Hulsmann C, Kummer MP, Heneka MT (2010) Distinct modulation of microglial amyloid beta phagocytosis and migration by neuropeptides (i). J\u00a0Neuroinflammation 7: 61","journal-title":"J\u00a0Neuroinflammation"},{"key":"BFEMMM201606370_CR15","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1016\/S0021-9258(17)41945-4","volume":"269","author":"S Greenberg","year":"1994","unstructured":"Greenberg S, Chang P, Silverstein SC (1994) Tyrosine phosphorylation of the gamma subunit of Fc gamma receptors, p72syk, and paxillin during Fc receptor\u2010mediated phagocytosis in macrophages. J Biol Chem 269: 3897\u20133902","journal-title":"J Biol Chem"},{"key":"BFEMMM201606370_CR16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S et\u00a0al (2013) TREM2 variants in Alzheimer's disease. N Engl J Med 368: 117\u2013127","journal-title":"N Engl J Med"},{"key":"BFEMMM201606370_CR17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.emboj.7600061","volume":"23","author":"C Haass","year":"2004","unstructured":"Haass C (2004) Take five\u2013BACE and the gamma\u2010secretase quartet conduct Alzheimer's amyloid beta\u2010peptide generation. EMBO J 23: 483\u2013488","journal-title":"EMBO J"},{"key":"BFEMMM201606370_CR18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353\u2013356","journal-title":"Science"},{"key":"BFEMMM201606370_CR19","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1471-4159.2009.06042.x","volume":"109","author":"CL Hsieh","year":"2009","unstructured":"Hsieh CL, Koike M, Spusta SC, Niemi EC, Yenari M, Nakamura MC, Seaman WE (2009) A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J Neurochem 109: 1144\u20131156","journal-title":"J Neurochem"},{"key":"BFEMMM201606370_CR20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.20142322","volume":"212","author":"TR Jay","year":"2015","unstructured":"Jay TR, Miller CM, Cheng PJ, Graham LC, Bemiller S, Broihier ML, Xu G, Margevicius D, Karlo JC, Sousa GL et\u00a0al (2015) TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. J Exp Med 212: 287\u2013295","journal-title":"J Exp Med"},{"key":"BFEMMM201606370_CR21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ et\u00a0al (2013) Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 368: 107\u2013116","journal-title":"N Engl J Med"},{"key":"BFEMMM201606370_CR22","doi-asserted-by":"crossref","first-page":"243ra286","DOI":"10.1126\/scitranslmed.3009093","volume":"6","author":"G Kleinberger","year":"2014","unstructured":"Kleinberger G, Yamanishi Y, Suarez\u2010Calvet M, Czirr E, Lohmann E, Cuyvers E, Struyfs H, Pettkus N, Wenninger\u2010Weinzierl A, Mazaheri F et\u00a0al (2014) TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med 6: 243ra286","journal-title":"Sci Transl Med"},{"key":"BFEMMM201606370_CR23","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1038\/emboj.2012.173","volume":"31","author":"PH Kuhn","year":"2012","unstructured":"Kuhn PH, Koroniak K, Hogl S, Colombo A, Zeitschel U, Willem M, Volbracht C, Schepers U, Imhof A, Hoffmeister A et\u00a0al (2012) Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons. EMBO J 31: 3157\u20133168","journal-title":"EMBO J"},{"key":"BFEMMM201606370_CR24","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/brain\/aww036","volume":"139","author":"A Lathuiliere","year":"2016","unstructured":"Lathuiliere A, Laversenne V, Astolfo A, Kopetzki E, Jacobsen H, Stampanoni M, Bohrmann B, Schneider BL, Aebischer P (2016) A subcutaneous cellular implant for passive immunization against amyloid\u2010beta reduces brain amyloid and tau pathologies. Brain 139: 1587\u20131604","journal-title":"Brain"},{"key":"BFEMMM201606370_CR25","doi-asserted-by":"crossref","first-page":"e15263","DOI":"10.1371\/journal.pone.0015263","volume":"5","author":"FM Marim","year":"2010","unstructured":"Marim FM, Silveira TN, Lima DS Jr, Zamboni DS (2010) A method for generation of bone marrow\u2010derived macrophages from cryopreserved mouse bone marrow cells. PLoS ONE 5: e15263","journal-title":"PLoS ONE"},{"key":"BFEMMM201606370_CR26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1212\/WNL.42.2.447","volume":"42","author":"PL McGeer","year":"1992","unstructured":"McGeer PL, Rogers J (1992) Anti\u2010inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 42: 447\u2013449","journal-title":"Neurology"},{"key":"BFEMMM201606370_CR27","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/35050116","volume":"408","author":"D Morgan","year":"2000","unstructured":"Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D et\u00a0al (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408: 982\u2013985","journal-title":"Nature"},{"key":"BFEMMM201606370_CR28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archneurol.2011.1538","volume":"69","author":"S Ostrowitzki","year":"2012","unstructured":"Ostrowitzki S, Deptula D, Thurfjell L, Barkhof F, Bohrmann B, Brooks DJ, Klunk WE, Ashford E, Yoo K, Xu ZX et\u00a0al (2012) Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. Arch Neurol 69: 198\u2013207","journal-title":"Arch Neurol"},{"key":"BFEMMM201606370_CR29","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.humimm.2013.02.003","volume":"74","author":"A Paradowska\u2010Gorycka","year":"2013","unstructured":"Paradowska\u2010Gorycka A, Jurkowska M (2013) Structure, expression pattern and biological activity of molecular complex TREM\u20102\/DAP12. Hum Immunol 74: 730\u2013737","journal-title":"Hum Immunol"},{"key":"BFEMMM201606370_CR30","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.embor.7400784","volume":"7","author":"R Radde","year":"2006","unstructured":"Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, Stoltze L, Calhoun ME, Jaggi F, Wolburg H, Gengler S et\u00a0al (2006) Abeta42\u2010driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 7: 940\u2013946","journal-title":"EMBO Rep"},{"key":"BFEMMM201606370_CR31","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F (2013) Genome engineering using the CRISPR\u2010Cas9 system. Nat Protoc 8: 2281\u20132308","journal-title":"Nat Protoc"},{"key":"BFEMMM201606370_CR32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-8-19","volume":"8","author":"S Rayaprolu","year":"2013","unstructured":"Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, Seeley WW, Hatanpaa KJ, Lomen\u2010Hoerth C, Kertesz A, Bigio EH et\u00a0al (2013) TREM2 in neurodegeneration: evidence for association of the p. R47H variant with frontotemporal dementia and Parkinson's disease. Mol Neurodegener 8: 19","journal-title":"Mol Neurodegener"},{"key":"BFEMMM201606370_CR33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nature.2015.18031","volume":"523","author":"S Reardon","year":"2015","unstructured":"Reardon S (2015) Antibody drugs for Alzheimer's show glimmers of promise. Nature 523: 509\u2013510","journal-title":"Nature"},{"key":"BFEMMM201606370_CR34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1474-4422(10)70043-0","volume":"9","author":"JO Rinne","year":"2010","unstructured":"Rinne JO, Brooks DJ, Rossor MN, Fox NC, Bullock R, Klunk WE, Mathis CA, Blennow K, Barakos J, Okello AA et\u00a0al (2010) 11C\u2010PiB PET assessment of change in fibrillar amyloid\u2010beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double\u2010blind, placebo\u2010controlled, ascending\u2010dose study. Lancet Neurol 9: 363\u2013372","journal-title":"Lancet Neurol"},{"key":"BFEMMM201606370_CR35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","volume":"400","author":"D Schenk","year":"1999","unstructured":"Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson\u2010Wood K, Khan K et\u00a0al (1999) Immunization with amyloid\u2010beta attenuates Alzheimer\u2010disease\u2010like pathology in the PDAPP mouse. Nature 400: 173\u2013177","journal-title":"Nature"},{"key":"BFEMMM201606370_CR36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25\u00a0years of image analysis. Nat Methods 9: 671\u2013675","journal-title":"Nat Methods"},{"key":"BFEMMM201606370_CR37","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1111\/j.1460-9568.2004.03729.x","volume":"20","author":"G Sessa","year":"2004","unstructured":"Sessa G, Podini P, Mariani M, Meroni A, Spreafico R, Sinigaglia F, Colonna M, Panina P, Meldolesi J (2004) Distribution and signaling of TREM2\/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia. Eur J Neurosci 20: 2617\u20132628","journal-title":"Eur J Neurosci"},{"key":"BFEMMM201606370_CR38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nbd.2007.04.011","volume":"27","author":"K Shirotani","year":"2007","unstructured":"Shirotani K, Tomioka M, Kremmer E, Haass C, Steiner H (2007) Pathological activity of familial Alzheimer's disease\u2010associated mutant presenilin can be executed by six different gamma\u2010secretase complexes. Neurobiol Dis 27: 102\u2013107","journal-title":"Neurobiol Dis"},{"key":"BFEMMM201606370_CR39","doi-asserted-by":"crossref","first-page":"466","DOI":"10.15252\/emmm.201506123","volume":"8","author":"M Suarez\u2010Calvet","year":"2016","unstructured":"Suarez\u2010Calvet M, Kleinberger G, Araque Caballero MA, Brendel M, Rominger A, Alcolea D, Fortea J, Lleo A, Blesa R, Gispert JD et\u00a0al (2016) sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early\u2010stage Alzheimer's disease and associate with neuronal injury markers. EMBO Mol Med 8: 466\u2013476","journal-title":"EMBO Mol Med"},{"key":"BFEMMM201606370_CR40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.20041611","volume":"201","author":"K Takahashi","year":"2005","unstructured":"Takahashi K, Rochford CD, Neumann H (2005) Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells\u20102. J Exp Med 201: 647\u2013657","journal-title":"J Exp Med"},{"key":"BFEMMM201606370_CR41","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1056\/NEJMcibr1503954","volume":"372","author":"RE Tanzi","year":"2015","unstructured":"Tanzi RE (2015) TREM2 and risk of Alzheimer's disease\u2010Friend or Foe? N Engl J Med 372: 2564\u20132565","journal-title":"N Engl J Med"},{"key":"BFEMMM201606370_CR42","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.4049\/jimmunol.177.6.3520","volume":"177","author":"IR Turnbull","year":"2006","unstructured":"Turnbull IR, Gilfillan S, Cella M, Aoshi T, Miller M, Piccio L, Hernandez M, Colonna M (2006) Cutting edge: TREM\u20102 attenuates macrophage activation. J Immunol 177: 3520\u20133524","journal-title":"J Immunol"},{"key":"BFEMMM201606370_CR43","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/acschemneuro.5b00313","volume":"7","author":"JD Ulrich","year":"2016","unstructured":"Ulrich JD, Holtzman DM (2016) TREM2 Function in Alzheimer's disease and neurodegeneration. ACS Chem Neurosci 7: 420\u2013427","journal-title":"ACS Chem Neurosci"},{"key":"BFEMMM201606370_CR44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.conb.2015.10.004","volume":"36","author":"C Villegas\u2010Llerena","year":"2016","unstructured":"Villegas\u2010Llerena C, Phillips A, Garcia\u2010Reitboeck P, Hardy J, Pocock JM (2016) Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease. Curr Opin Neurobiol 36: 74\u201381","journal-title":"Curr Opin Neurobiol"},{"key":"BFEMMM201606370_CR45","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, Gilfillan S, Krishnan GM, Sudhakar S, Zinselmeyer BH et\u00a0al (2015) TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell 160: 1061\u20131071","journal-title":"Cell"},{"key":"BFEMMM201606370_CR46","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang Y, Ulland TK, Ulrich JD, Song W, Tzaferis JA, Hole JT, Yuan P, Mahan TE, Shi Y, Gilfillan S et\u00a0al (2016) TREM2\u2010mediated early microglial response limits diffusion and toxicity of amyloid plaques. J Exp Med 213: 667\u2013675","journal-title":"J Exp Med"},{"key":"BFEMMM201606370_CR47","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1126\/science.1132341","volume":"314","author":"M Willem","year":"2006","unstructured":"Willem M, Garratt AN, Novak B, Citron M, Kaufmann S, Rittger A, DeStrooper B, Saftig P, Birchmeier C, Haass C (2006) Control of peripheral nerve myelination by the beta\u2010secretase BACE1. Science 314: 664\u2013666","journal-title":"Science"},{"key":"BFEMMM201606370_CR48","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature14864","volume":"526","author":"M Willem","year":"2015","unstructured":"Willem M, Tahirovic S, Busche MA, Ovsepian SV, Chafai M, Kootar S, Hornburg D, Evans LD, Moore S, Daria A et\u00a0al (2015) eta\u2010Secretase processing of APP inhibits neuronal activity in the hippocampus. Nature 526: 443\u2013447","journal-title":"Nature"},{"key":"BFEMMM201606370_CR49","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.neuron.2014.12.064","volume":"85","author":"T Wisniewski","year":"2015","unstructured":"Wisniewski T, Goni F (2015) Immunotherapeutic approaches for Alzheimer's disease. Neuron 85: 1162\u20131176","journal-title":"Neuron"},{"key":"BFEMMM201606370_CR50","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1084\/jem.20141732","volume":"212","author":"K Wu","year":"2015","unstructured":"Wu K, Byers DE, Jin X, Agapov E, Alexander\u2010Brett J, Patel AC, Cella M, Gilfilan S, Colonna M, Kober DL et\u00a0al (2015) TREM\u20102 promotes macrophage survival and lung disease after respiratory viral infection. J Exp Med 212: 681\u2013697","journal-title":"J Exp Med"},{"key":"BFEMMM201606370_CR51","doi-asserted-by":"crossref","first-page":"25927","DOI":"10.1074\/jbc.M112.377465","volume":"287","author":"L Zhou","year":"2012","unstructured":"Zhou L, Barao S, Laga M, Bockstael K, Borgers M, Gijsen H, Annaert W, Moechars D, Mercken M, Gevaert K et\u00a0al (2012) The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in\u00a0vivo. J Biol Chem 287: 25927\u201325940","journal-title":"J Biol Chem"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201606370.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.201606370","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.201606370\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.201606370","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201606370.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:19:51Z","timestamp":1779085191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.201606370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,8]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9,1]]}},"alternative-id":["BFEMMM201606370"],"URL":"https:\/\/doi.org\/10.15252\/emmm.201606370","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,8]]},"assertion":[{"value":"10 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.H. is an advisor of F. Hoffmann\u2010La Roche. I.K. and B.B. are full\u2010time employees at Roche. All other authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}